The contributions of TGF-β signaling to cancer are complex but involve the inflammatory microenvironment as well as cancer cells themselves. In mice encoding a TGF-β mutant that precludes its binding to the latent TGF-β binding protein (Tgfb1   -/C33S ), we observed multiorgan inflammation and an elevated incidence of various types of gastrointestinal solid tumors due to impaired conversion of latent to active TGF-β1. By genetically eliminating activators of latent TGF-β1, we further lowered the amount of TGF-β, which enhanced tumor frequency and multiorgan inflammation. This model system was used to further investigate the relative contribution of TGF-β1 to lymphocyte-mediated inflammation in gastrointestinal tumorigenesis. Toward this end, we generated Tgfb1 ;Rag2 -/-mice exhibited reduced paracrine signaling in the epithelia, mediated by hepatocyte growth factor produced by gastric stroma. Together, our results indicate that many of the responses of the gastric tissue associated with decreased TGF-β1 may be directly or indirectly affected by inflammatory processes, which accompany loss of TGF-β1, rather than a direct effect of loss of the cytokine.
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Introduction TGF-β1 was described as a stimulator of mesenchymal cell growth (1) . However, subsequent studies revealed that this cytokine also has an important function as an inhibitor of epithelial cell proliferation. As such, TGF-β1 acts as a tumor suppressor, a view supported by data from numerous human and animal studies demonstrating that inactivating mutations in the TGF-β signaling pathway result in different types of carcinomas (2) . The multiple and sometimes apparently contradictory actions of TGF-β1 are also evident by the fact that, whereas TGF-β1 is a growth suppressor in early stage tumors, it may have a promoting effect in late stage tumors (3) (4) (5) (6) . The reasons for this difference in response to TGF-β are unclear but may relate to the acquisition of mutations by later stage tumors that block TGF-β's growth inhibiting activity but accentuate its ability to initiate an epithelial to mesenchymal transition, a process that enhances the invasive and metastatic phenotypes (7) .
In addition to its growth regulatory capacity, a second important property of TGF-β1 is the promotion of T regulatory cell maturation and the consequent suppression of inflammation (8) . Thus, TGF-β1 null mutations in mice are associated with severe multiorgan inflammation and rapid death after weaning (9, 10) . Since inflammation and inflammatory mediators promote tumor formation, loss of TGF-β or loss of TGF-β signaling might have a dual effect upon tumorigenesis both by relieving the growth suppressive activity and by initiating the stimulation associated with inflammation.
Research. There are three TGF-β genes (Tgfb1, 2, and 3). Mutations of TGF-β2 or TGF-β3 genes are not known to be associated with tumor production (11) (12) (13) . Loss of TGF-β1 results in severe multiorgan inflammation and early death (9, 10) . Tumor generation has also been reported in TGF-β1 null mice but has been difficult to study because of rapid death after weaning due to the strong phenotype.
To circumvent this problem, we generated TGF-β1 hypomorphic mice by permuting the mechanism utilized to generate active TGF-β1 (14) . Although all TGF-βs are initially produced as homodimeric proproteins and the bond between the prosequence and the mature molecule is cleaved within the cell, the propeptide, named the latency associated protein (LAP), remains associated with the signaling molecule after secretion (15) . This complex of TGF-β and LAP is called the small latent complex (SLC). The continued interaction of cytokine with its propeptide renders TGF-β latent, since in this form TGF-β cannot interact with its receptor. A variety of mechanisms for the activation, i.e. the liberation of TGF-β from the SLC, of latent TGF-β have been described and all involve the perturbation of the binding between TGF-β and LAP by integrins, proteases, thrombospondin 1, or reactive oxygen (15) . The TGF-β-LAP complex is usually linked to a second gene product, a latent TGF-β binding protein (LTBP), through cysteine residues in LAP forming the large latent complex (LLC). Four LTBP genes exist; three of which, LTBP-1, -3, and -4, bind to TGF-β LAP isoforms (16) .
LTBPs target the latent TGF-β complex to the matrix and may participate indirectly in activation of the latent complex by the integrin αvβ6 (15 process depends upon the integrin binding to an RGD sequence in the TGF-β1
propeptide and the latent complex binding to the matrix via the LTBP. When the cell applies force to the complex by cytoskeleton contraction mediated by the integrin, tethering to the matrix via the LTBP results in distortion of the TGF-β1-LAP complex and release of active TGF-β1 (17, 18) . Mutation of either the RGD to a non-integrin binding sequence (RGE) or deletion of the matrix-binding regions in LTBP blocks latent TGF-β activation (19, 20) .
To perturb latent TGF-β activation, we mutated the TGF-β1 LAP cysteine (residue 33), which binds LTBP, to serine (14) . Thus, TGF-β1 produced by these mutant genotype yielded high numbers of gastric tumors, an effect not observed in other models of TGF-β1 deficiency (14, 22) . Concomitant with the increase in tumors, we observed a decrease in TGF-β signaling and a concordant increase in the degree of inflammation (21) . Therefore, Tgfb1
C33S/C33S
mice provide a system in which the level of active TGF-β1 can be manipulated genetically and the properties of selective phenotypes examined over an extended period of time.
We hypothesized that we could use mice. We found that in the compound mutant animals, the loss of gastric tumor production is accompanied by reductions in IL-1β and IL-6 cytokine production as well as decreased signaling through the hepatocyte growth factor (HGF) receptor cMet, and cRon. TGF-β Assays. The levels of total and active TGF-β1 were measured in sera using a mouse TGF-β1 duo-set (DY1679) according to the manufacturer's instructions (R&D Systems, Minneapolis, USA).
Histology. Stomach and rectal tissues were dissected, opened and the contents flushed with ice-cold saline. The tissue was immersed and fixed in 10% formalin and embedded in paraffin. Each tissue was serial sectioned and a minimum of 5 H&E-stained sections were examined that were at least 100 μm apart.
Pathological Scoring of Inflammation.
A scoring system in which three parameters were monitored in individual histological sections was used for quantification of inflammation (14, 21) . The three parameters were; 1) Inflammation, measured as cell Immunohistochemistry. Preparation of tissues, sectioning, and antibody staining were performed as described (14) . Antibodies used were purchased from the following KI67 and P Histone H3 analysis -Staining and analysis were performed as described (21) .
Image analysis
Stained slides were scanned using a Leica SCN400F. Slides were analyzed using Ariol image analysis system. The settings were adjusted in a process called 'training of Research. 
-/C33S mice were increased compared to Wt, presumably because of inflammation (Supplemental Fig. 1C and D tissues when normalized to total body weight (Fig. 1A) . The degree of inflammation, as measured by a system that scored inflammatory cell infiltration and edema, hyperplasia, and necrosis, was elevated ;Rag2 -/-mice ( Fig. 1D-F) . In the stomach of double mutant animals, there was an absence of T cells and fewer macrophages in the tissues of
Tgfb1 -/C33S
;Rag2 -/-mice ( Fig. 1D-I ;Rag2 -/-sera compared to Wt (Supplemental Fig. 1E ), as expected. However, total TGF-β1 was significantly lower than the 50% expected for these two mutant genotypes.
The reason for this is not clear but was also observed in our earlier studies (21) . It is possible that the SLC is less stable in serum than the LLC. The amount of active TGF- compared to Wt (Fig. 2A, B , and D). P-Smad3 levels were restored to the level of Wt in Tgfb1 -/C33S ;Rag2 -/-tissue ( Fig. 2C and D) . This result was unexpected, as we assumed TGF-β activation and, therefore, TGF-β signaling would remain low in the
;Rag2 -/-mice. It is possible that in the absence of T and B cells, there is compensation by other ligands that might increase P-Smad3 levels.
In a second approach, we examined the expression of TGF-β-sensitive genes in mice of the different genotypes (14, 26 mutants, consistent with lack of an increase in active TGF-β1 in the mutant genotypes (Fig. 2E) .
Tumor Incidence

Tgfb1 -/C33S
mice had an overall incidence of stomach and rectal tumors of 40% at 16-19 weeks (Table 1 ). All tumors were well-differentiated adenocarcinomas (Fig. 3) and all but one of the stomach tumors were invasive. No metastases were observed.
The tumor incidence was slightly less than observed previously (21) . This may reflect the genetic background as the animals in this study were in a primarily C57BL/129 background, whereas animals in our earlier studies were outbred. No tumors were found in the stomach or rectum of Tgfb1 -/C33S ;Rag2 -/-mice ( Table 1) . We therefore concluded that decreasing the inflammatory response impeded tumor development. granulocytes in early tumor stages, but we failed to observe this. Indeed, we detected very little hyperplasia. There are several technical differences between our model and that of Engle et al., that might account for the apparently conflicting results. Perhaps the most significant difference is that our animals are TGF-β1 hypomorphs, whereas the animals that Engel et al. studied were TGF-β1 nulls. Thus, tumor type may reflect the absolute level of TGF-β1. In addition, Engle et al. used 129 x CF-1 mice, whereas our mice were on a primarily C57BL6 background. Individual mouse strains may exhibit unique responses to TGF-β1 loss due to differences in modifier genes.
Prevention of tumors in
We quantified the numbers of proliferating cells by scoring for Ki67 positive cells (Fig. 4) . Gastric tissue samples from Wt mice had low numbers of positive cells (Fig. 4A and D), whereas the samples from Tgfb1
mice had a high number of Ki67-reactive cells ( Fig. 4B and D) . Thus, decreasing TGF-β1 levels results in enhanced proliferation, (Figs. 4E-H) . Therefore, increased cell proliferation as measured by two markers, correlated with the degree of inflammation. The potential complexity of the contribution of inflammation to tumor production is further highlighted in a recent paper (27) 
Cytokine Signaling
To determine the potential inflammatory stimuli contributing to tumor generation, we used qPCR to screen stomach tissue of the different genotypes for a number of cytokines associated with tumor generation (Fig. 5A) . The assay revealed increased levels of IL-1β and IL-6 expression in Tgfb1 -/C33S tissue compared to Wt or Rag2 -/-samples. This is consistent with the diminution in Th17 cells we reported earlier (28) .
Both IL-1β and IL-6 have been associated with enhanced tumorigenesis (29, 30) . These increases in gene expression were reversed by introduction of the Rag2 -/-mutation ( Fig.   5A ). Heightened levels of IL-10, Mip1α, and Mip1β were also observed in Tgfb1
samples, but these changes were at the limit of statistical significance. We examined IL-1β and IL-6 protein levels in tissues by ELISA but we were unable to detect changes in either gastric tissue or in the sera of Tgfb1 ;Rag2 -/-animals ( Fig. 5B-E) . The expression of three genes, Mmp13, Survivin, and Bcl-xl, whose expression is enhanced by P-Stat3, was assayed (32) (33) (34) . mice.
An earlier report using a conditional deletion of the TGF-β receptor (TβRII) in fibroblasts described gastric tumor formation in TβRII-deficient mice (35) . In that system, tumor induction was mediated through a paracrine mechanism in which loss of TGF-β signaling in gastric stroma resulted in enhanced expression of HGF, which stimulated the growth of epithelial cells. Therefore, we examined gastric tissues for HGF levels, as measured by IHC and qPCR. Staining with an antibody for HGF revealed no staining in Wt tissue. In samples from Tgfb1
mice, staining occurred in a pattern corresponding to the morphology of stromal fibroblasts or smooth muscle cells (Fig. 6A-C ). To validate that the HGF-positive cells were fibroblasts, we performed colocalization studies using the antibodies to HGF and calponin, a marker for stromal non-epithelial cells (36) . We observed coincidence of the two markers (Fig. 6Q-S (Fig. 6D) .
Coincident with the increased expression of HGF in Tgfb1 -/C33S
tissue, there was an increase (7-fold) in cells positive for activated HGF receptor (P-cMet) (Fig. 6E-H ).
This increase was not observed in stomach tissue from Tgfb1 -/C33S
;Rag2 -/-mice. We also examined the tissues for P-Ron, as concomitant increases in P-Ron have been reported upon decreased TGF-β signaling (37, 38) . As with P-cMet, staining was 
6I-L).
We next examined tissues for the level of the downstream mediator of P-cMet, PErk ( Fig. 6M-P) . There was a large increase (∼ 4 fold) in the percentage of cells that were positive for P-Erk and this increase was reduced by more than 50% when Tgfb1 
